Hsu FS - Search Results

1

Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis.

Lin WC, Chiu YL, Kuo KL, Chow PM, Hsu CH, Liao SM, Dong JR, Chang SC, Liu SH, Liu TJ, Hsu FS, Wang KC, Lin YC, Chang CC, Huang KY. Lin WC, et al. Among authors: hsu fs. Am J Cancer Res. 2023 Jul 15;13(7):3055-3066. eCollection 2023. Am J Cancer Res. 2023. PMID: 37559983 Free PMC article.

2

THZ1, a covalent CDK7 inhibitor, enhances gemcitabine-induced cytotoxicity via suppression of Bcl-2 in urothelial carcinoma.

Kuo KL, Lin WC, Liu SH, Hsu FS, Kuo Y, Liao SM, Yang SP, Wang ZH, Hsu CH, Huang KH. Kuo KL, et al. Among authors: hsu fs. Am J Cancer Res. 2021 Jan 1;11(1):171-180. eCollection 2021. Am J Cancer Res. 2021. PMID: 33520367 Free PMC article.

3

Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma.

Lin WC, Hsu FS, Kuo KL, Liu SH, Shun CT, Shi CS, Chang HC, Tsai YC, Lin MC, Wu JT, Kuo Y, Chow PM, Liao SM, Yang SP, Hong JY, Huang KH. Lin WC, et al. Among authors: hsu fs. J Mol Med (Berl). 2018 Dec;96(12):1307-1318. doi: 10.1007/s00109-018-1697-7. Epub 2018 Oct 4. J Mol Med (Berl). 2018. PMID: 30288546

4

Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.

Kuo KL, Liu SH, Lin WC, Hsu FS, Chow PM, Chang YW, Yang SP, Shi CS, Hsu CH, Liao SM, Chang HC, Huang KH. Kuo KL, et al. Among authors: hsu fs, hsu ch. Int J Mol Sci. 2019 Jun 30;20(13):3218. doi: 10.3390/ijms20133218. Int J Mol Sci. 2019. PMID: 31262032 Free PMC article.

5

Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study.

Shi CS, Kuo KL, Chen MS, Chow PM, Liu SH, Chang YW, Lin WC, Liao SM, Hsu CH, Hsu FS, Chang HC, Huang KH. Shi CS, et al. Among authors: hsu fs, hsu ch. Cells. 2019 Nov 19;8(11):1469. doi: 10.3390/cells8111469. Cells. 2019. PMID: 31752390 Free PMC article.

6

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.

Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, Dong JR, Liu SH, Chang SC, Yang SP, Chen YT, Chang RJ, Huang KH. Hsu FS, et al. Int J Mol Sci. 2021 Oct 28;22(21):11706. doi: 10.3390/ijms222111706. Int J Mol Sci. 2021. PMID: 34769137 Free PMC article.

7

Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma.

Lin WC, Hsu FS, Kuo KL, Liu SH, Shun CT, Shi CS, Chang HC, Tsai YC, Lin MC, Wu JT, Kuo Y, Chow PM, Liao SM, Yang SP, Hong JY, Huang KH. Lin WC, et al. Among authors: hsu fs. J Mol Med (Berl). 2019 Mar;97(3):435-436. doi: 10.1007/s00109-019-01748-2. J Mol Med (Berl). 2019. PMID: 30741319

8

Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.

Hsu FS, Wu JT, Lin JY, Yang SP, Kuo KL, Lin WC, Shi CS, Chow PM, Liao SM, Pan CI, Hong JY, Chang HC, Huang KH. Hsu FS, et al. Int J Mol Sci. 2019 Mar 7;20(5):1162. doi: 10.3390/ijms20051162. Int J Mol Sci. 2019. PMID: 30866433 Free PMC article.

9

A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma.

Hsu FS, Su CH, Huang KH. Hsu FS, et al. J Immunol Res. 2017;2017:6940546. doi: 10.1155/2017/6940546. Epub 2017 Dec 10. J Immunol Res. 2017. PMID: 29376081 Free PMC article. Review.

10

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.

Liu CW, Chang WC, Lee CC, Shau WY, Hsu FS, Wang ML, Chen TC, Lo C, Hwang JJ. Liu CW, et al. Among authors: hsu fs. Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1011-1022. doi: 10.1016/j.numecd.2019.06.016. Epub 2019 Jun 24. Nutr Metab Cardiovasc Dis. 2019. PMID: 31378626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters